Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size of chronic obstructive pulmonary disease (COPD) and asthma devices have seen significant growth over the recent years. The market is predicted to expand from $44.95 billion in 2024 to $47.56 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the historical period can be linked to the increase in older population, a rise in allergies, amplified government undertakings, an upswing in clinical research and trials, and accelerated urbanization.
Considerable expansion is forecasted for the chronic obstructive pulmonary disease (copd) and asthma devices market in the next few years, with predictions of it reaching a value of $59.46 billion in 2029, equating to a compound annual growth rate (CAGR) of 5.7%. The augmentation over this predicted period is believed to be fueled by an increased prevalence of respiratory diseases, a surge in cigarette consumption, elevated levels of environmental pollutants and breathing difficulties. Other contributing factors include rising healthcare costs and the enhanced portability of drug delivery devices. The forecast period also hints at significant trends including technological progress, the incorporation of cutting-edge technology, tailored medicine, the use of biologics and the application of wearable respiratory monitoring devices.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
What External and Internal Drivers Are Contributing to the Growth of theChronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The escalating incidence of ailments that affect respiration is predicted to stimulate the expansion of the COPD and asthma devices market in the future. Respiratory disorders include a vast array of conditions that impact the lungs and respiratory systems, such as COPD, asthma, pneumonia, and lung cancer, thereby affecting breathing and overall respiration functionality. Surge in respiratory ailments can be attributed to rising levels of air pollution, alterations in climate patterns that influence allergens and pathogens, and lifestyle choices like smoking, which jeopardize respiratory wellness. Devices for COPD and asthma are integral to the holistic management and therapy of respiratory ailments, enabling patients to improve their respiratory health and overall quality of life. For instance, in March 2023, as per the World Health Organization (WHO), a specialized UN agency based in Switzerland focusing on worldwide public health, COPD was identified as the third leading cause of death worldwide, responsible for roughly 3.23 million deaths. Additionally, about 90% of these deaths in people below 70 years were reported in low- and middle-income nations. Consequently, the escalating incidence of respiratory disorders is fueling the expansion of the COPD and asthma devices market.
What Segment Types Define the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Structure?
The chronic obstructive pulmonary disease (copd) and asthma devicesmarket covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2024. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major firms in the market of chronic obstructive pulmonary disease (COPD) and asthma devices are leaning towards the creation of novel technologies such as inhalation devices. These devices are intended to amalgamate digital health characteristics, allowing for distant tracking and bespoke treatment management. Inhalation devices serve as medical tools that facilitate the direct delivery of medications into the patient’s lungs. For instance, Alkem Laboratories, a pharmaceutical company based in India, launched the Innohaler in May of 2022. This Dry Powder Inhaler (DPI) device simplifies the lives of COPD and asthma patients. The cutting-edge breath-actuated technology of the Innohaler guarantees accurate medicine delivery with each inhalation, optimizing dosage precision and minimizing wastage. The device’s ergonomic construction provides ease of operation, incorporating a user-friendly interface that makes it simple to operate for individuals of all age groups. Boasting a compact and easily transportable design, the device enhances comfort for mobile use and serves to improve patients’ compliance with prescribed regimens.
View the full report here:
What Is the Definition of the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Chronic obstructive pulmonary disease (COPD) and asthma devices refer to the medical devices used to manage and treat breathing and respiratory conditions. These devices help patients breathe more effectively, manage symptoms, and improve their quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
